Poinsettia (300723.SZ) subsidiary obtained a registration certificate for concentrated solution of sodium valproate for injection

Zhitongcaijing · 2d ago

Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Guangzhou Lianrui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration for concentrated solution of sodium valproate for injection.

This time, the company obtained a registration certificate for concentrated sodium valproate solution, indicating that the company is qualified to sell drugs of this specification in the domestic market, which will further enrich the company's product pipeline and product categories, and enhance the company's competitiveness in chronic disease drugs.